REPORTS

Let’s Pullulate and Expand Your Business

Pharmaceutical Intermediates and API Market - Global Professional Analysis and Forecast to 2026

Oct 22, 2019  |  143 PAGES  |  REPORT CODE: CMM221164
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pharmaceutical Intermediates and API market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the Pharmaceutical Intermediates and API market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Intermediates and API market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Intermediates and API industry and will help you to build a panoramic view of the industrial development.

Pharmaceutical Intermediates and API Market, By Type:

  • Chiral Building Blocks

  • Achiral Building Blocks

Pharmaceutical Intermediates and API Market, By Application:

  • Pharmaceutical Companies

  • Research Labs

  • Contract Manufacturing Organizations

  • Other Industries

Some of the leading players are as follows:

  • Cycle Pharma Chem

  • Aceto Corporation

  • Vertellus Holdings LLC

  • Midas Pharma GmbH

  • Cipla

  • Dr. Reddy's Laboratories Ltd.

  • Lianhetech

  • Easter Chemical Corporation

  • BASF SE

  • ZCL Chemical Ltd.

  • Codexis

  • Aurobindo Pharma Limited

  • TEVA

  • Chemcon Specialty Chemical Pvt. Ltd.

  • Novartis China

  • Dextra Laboratories Limited

  • Dishman Group

  • A.R. Life Sciences Private Limited

  • Sanofi Winthrop Industries

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pharmaceutical Intermediates and API Market: Technology Type Analysis

  • 4.1 Pharmaceutical Intermediates and API Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pharmaceutical Intermediates and API Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Chiral Building Blocks

    • 4.3.2 Achiral Building Blocks

5 Pharmaceutical Intermediates and API Market: Product Analysis

  • 5.1 Pharmaceutical Intermediates and API Product Market Share Analysis, 2018 & 2026

  • 5.2 Pharmaceutical Intermediates and API Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pharmaceutical Intermediates and API Market: Application Analysis

  • 6.1 Pharmaceutical Intermediates and API Application Market Share Analysis, 2018 & 2026

  • 6.2 Pharmaceutical Intermediates and API Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pharmaceutical Companies

    • 6.3.2 Research Labs

    • 6.3.3 Contract Manufacturing Organizations

    • 6.3.4 Other Industries

7 Pharmaceutical Intermediates and API Market: Regional Analysis

  • 7.1 Pharmaceutical Intermediates and API Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pharmaceutical Intermediates and API Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Cycle Pharma Chem

    • 9.1.1 Cycle Pharma Chem Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Aceto Corporation

    • 9.2.1 Aceto Corporation Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Vertellus Holdings LLC

    • 9.3.1 Vertellus Holdings LLC Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Midas Pharma GmbH

    • 9.4.1 Midas Pharma GmbH Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Cipla

    • 9.5.1 Cipla Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Dr. Reddy's Laboratories Ltd.

    • 9.6.1 Dr. Reddy's Laboratories Ltd. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Lianhetech

    • 9.7.1 Lianhetech Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Easter Chemical Corporation

    • 9.8.1 Easter Chemical Corporation Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 BASF SE

    • 9.9.1 BASF SE Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 ZCL Chemical Ltd.

    • 9.10.1 ZCL Chemical Ltd. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Codexis

    • 9.11.1 Codexis Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Aurobindo Pharma Limited

    • 9.12.1 Aurobindo Pharma Limited Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 TEVA

    • 9.13.1 TEVA Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Chemcon Specialty Chemical Pvt. Ltd.

    • 9.14.1 Chemcon Specialty Chemical Pvt. Ltd. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Novartis China

    • 9.15.1 Novartis China Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Dextra Laboratories Limited

    • 9.16.1 Dextra Laboratories Limited Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Dishman Group

    • 9.17.1 Dishman Group Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 A.R. Life Sciences Private Limited

    • 9.18.1 A.R. Life Sciences Private Limited Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Sanofi Winthrop Industries

    • 9.19.1 Sanofi Winthrop Industries Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

 

The List of Tables and Figures (Totals 89 Figures and 122 Tables)

  • Figure Chiral Building Blocks Pharmaceutical Intermediates and API market, 2015 - 2026 (USD Million)

  • Figure Achiral Building Blocks Pharmaceutical Intermediates and API market, 2015 - 2026 (USD Million)

  • Figure Pharmaceutical Companies market, 2015 - 2026 (USD Million)

  • Figure Research Labs market, 2015 - 2026 (USD Million)

  • Figure Contract Manufacturing Organizations market, 2015 - 2026 (USD Million)

  • Figure Other Industries market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Cycle Pharma Chem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aceto Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vertellus Holdings LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Midas Pharma GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cipla Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dr. Reddy's Laboratories Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lianhetech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Easter Chemical Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BASF SE Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ZCL Chemical Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Codexis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Pharma Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TEVA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Chemcon Specialty Chemical Pvt. Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis China Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dextra Laboratories Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dishman Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table A.R. Life Sciences Private Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Winthrop Industries Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top